TNFRSF10B and cancer: The cellular ROS level is a critical mediator for DR5 expression, our in vivo and in vitro results showed that cell lines with NQO2 deletion or inactivated mutation (F178A) exhibited ROS generation, which was an essential signal for sensitizing cancer cells to TRAIL exposure via activating CHOP‐DR5 pathway (Figure 8).